Dubai: A new executive committee has taken charge at the Pharmaceutical Research and Manufacturers Association Gulf for the ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename ...

Life science company Epitopea, rooted in Cambridge UK and both Montreal and Quebec in Canada, has clinched a licensing deal ...

MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret ...

Life science company Epitopea, rooted in Cambridge UK and both Montreal and Quebec in Canada, has clinched a licensing deal and research collaboration with MSD that is potentially worth several ...

The EC has conditionally approved MSD's Welireg as a single agent for the treatment of adults with VHL disease and advanced ...

South Korea-based Hanmi Pharmaceutical has reported positive outcomes from a Phase I/II clinical trial of Tivumecirnon ...

This is a 20% increase from the previous year. It indicates that investments in the pharmaceutical sector are increasingly concentrated in China. U.S. company Merck (MSD) signed an exclusive license ...

Hanmi Pharmaceutical confirms positive results for Tibumeshirnon and Keytruda in cancer trial Phase 2 trial highlights ...

MSD Ireland's robust R&D pipeline of therapeutic projects ensures it is ready to meet the diverse needs of patients globally ...